“Assessment of Pressor Effects of Drugs”—A New US FDA Draft Guidance for Industry

被引：0

|

作者：

J. Rick Turner

机构：

来源：

Therapeutic Innovation & Regulatory Science | 2018年 / 52卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：397 / 399

页数：2

相关论文

共 50 条

[31] Recommendations for the Assessment of Blend and Content Uniformity: Modifications to Withdrawn FDA Draft Stratified Sampling Guidance
Thomas Garcia
James Bergum
James Prescott
Ravindra Tejwani
Thomas Parks
Jon Clark
William Brown
Fernando Muzzio
Samir Patel
Charles Hoiberg
Journal of Pharmaceutical Innovation, 2015, 10 : 76 - 83
[32] FDA's New Guidance for Industry Addressing Evaluation of the Safety of New Drugs for Improving Glycemic Control: A Case Study in Regulatory Science
Rick Turner, J.
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2021, 55 (01) : 1 - 5
[33] FDA’s New Guidance for Industry Addressing Evaluation of the Safety of New Drugs for Improving Glycemic Control: A Case Study in Regulatory Science
J. Rick Turner
Therapeutic Innovation & Regulatory Science, 2021, 55 : 1 - 5
[34] Regulatory Forum Opinion Piece: Review of FDA Draft Guidance Testicular Toxicity-Evaluation during Drug Development Guidance for Industry
Hukkanen, Renee R.
Halpern, Wendy G.
Vidal, Justin D.
TOXICOLOGIC PATHOLOGY, 2016, 44 (07) : 927 - 930
[35] Biosimilarity and Interchangeability in the Biologics Price Competition and Innovation Act of 2009 and FDA's 2012 Draft Guidance for Industry
Koyfman, Hannah
BIOTECHNOLOGY LAW REPORT, 2013, 32 (04) : 238 - 251
[36] Commentary on the FDA draft guidance for bioequivalence studies for nasal aerosols and nasal sprays for local action: An industry view
Harrison, LI
JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 40 (07): : 701 - 707
[37] The Indian Central Drugs Standard Control Organisation (CDSCO) has issued draft guidance for industry
Reactions Weekly, 2011, 1353 (1) : 2 - 2
[38] 2012 FDA DRAFT GUIDANCE FOR CYP INDUCTION OF INVESTIGATIONAL NEW DRUG CANDIDATES: THEORY AND PRACTICE
Hingorani, Gary
Rhodes, Susan P.
Hartley, Dylan P.
Franklin, Ronald B.
DRUG METABOLISM REVIEWS, 2012, 44 : 78 - 79
[39] Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer's disease
Harrison, John E.
ALZHEIMERS RESEARCH & THERAPY, 2018, 10
[40] Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease
John E. Harrison
Alzheimer's Research & Therapy, 10

← 1 2 3 4 5 →